Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials

被引:59
|
作者
Meissner, Karin [1 ]
Distel, Hans [1 ]
Mitzdorf, Ulla [1 ]
机构
[1] Univ Munich, Inst Med Psychol, D-8000 Munich, Germany
关键词
D O I
10.1186/1741-7015-5-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent reviews on placebo effects in clinical trials suggest that objective changes following placebo treatments may not exist or, at least, have been considerably overestimated. However, the possibility that yet unidentified subsets of parameters are responsive to placebo treatments has not been taken into account. Therefore, the aim of the present study is to examine the effects of placebo treatments on objectively measured outcome parameters by specifically focusing on peripheral disease processes. Methods: An initial dataset was collected from a MEDLINE search for placebo-controlled, randomized clinical trials. Trials with stable disease conditions were identified, and the effects of placebo treatments on peripheral outcome parameters were estimated by the changes from baseline in the placebo groups. An explorative data analysis was conducted in order to identify parameter classes with differential responsiveness to placebo treatments. A subgroup meta-analysis of a second dataset was performed to test whether the preliminary classification would also apply to placebo effects derived from the comparison of placebo groups with untreated control groups. Results: The explorative analysis of outcome parameters and strength of placebo effects yielded a classification into responsive "physical" versus non-responsive "biochemical" parameters. In total, 50% of trials measuring physical parameters showed significant placebo effects, compared with 6% of trials measuring biochemical parameters. A subgroup meta-analysis substantiated the differential response ( physical parameters: n = 14, Hedges' pooled effect size g = 0.34, 95% CI 0.22 to 0.46; biochemical parameters: n = 15, g = 0.03, 95% CI - 0.04 to 0.10). The subanalysis of the second dataset supported the classification and revealed a significant improvement for physical parameters ( n = 20, g = 0.22, 95% CI 0.07 to 0.36) and a deterioration for biochemical parameters ( n = 6, g = - 0.17, 95% CI - 0.31 to - 0.02). Conclusion: The results suggest that placebo interventions can improve physical disease processes of peripheral organs more easily and effectively than biochemical processes. This differential response offers a good starting point for theoretical considerations on possible mediating mechanisms, and for future investigations in this field.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Interventions to reduce the placebo response in clinical trials: a review of the literature
    Lanier, R.
    Erpelding, N.
    Treister, R.
    Lawal, D.
    Mohanty, M.
    Edler, H.
    Katz, N.
    JOURNAL OF PAIN, 2017, 18 (04): : S90 - S90
  • [22] CLINICAL AND BIOCHEMICAL PARAMETERS TO PREDICT OUTCOME IN SEPSIS AT ICU ADMISSION
    De la Torre-Prados, M. -V.
    Garcia-de la Torre, A.
    Trujillano-Fernandez, C.
    Zamboschi, N.
    Enguix-Armada, A.
    Garcia-Alcantara, A.
    Ortiz-Garcia, C.
    INTENSIVE CARE MEDICINE, 2011, 37 : S143 - S143
  • [23] The effects of boron on some biochemical parameters: A review
    Kan, Fahriye
    Kucukkurt, Ismail
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2023, 79
  • [24] Dystrophin as a biochemical outcome measure in Duchenne muscular dystrophy clinical trials
    Sardone, V.
    Ellis, M.
    Torelli, S.
    Feng, L.
    Chambers, D.
    Ricotti, V.
    Domingos, J. Pisco
    Phadke, R.
    Sewry, C. A.
    Morgan, J.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S16 - S16
  • [25] Speech audiometric outcome parameters in clinical trials on hearing improvement
    Mueller, J.
    Plontke, S. K.
    Rahne, T.
    HNO, 2017, 65 (03) : 211 - 218
  • [26] Validity of food additive maltodextrin as placebo and effects on human gut physiology: systematic review of placebo-controlled clinical trials
    Rawan Almutairi
    Abigail Raffner Basson
    Pamela Wearsh
    Fabio Cominelli
    Alexander Rodriguez-Palacios
    European Journal of Nutrition, 2022, 61 : 2853 - 2871
  • [27] Correction to: Validity of food additive maltodextrin as placebo and effects on human gut physiology: systematic review of placebo‑controlled clinical trials
    Rawan Almutairi
    Abigail Raffner Basson
    Pamela A. Wearsch
    Fabio Cominelli
    Alexander Rodriguez-Palacios
    European Journal of Nutrition, 2023, 62 : 2345 - 2345
  • [29] Validity of food additive maltodextrin as placebo and effects on human gut physiology: systematic review of placebo-controlled clinical trials
    Almutairi, Rawan
    Basson, Abigail Raffner
    Wearsh, Pamela
    Cominelli, Fabio
    Rodriguez-Palacios, Alexander
    EUROPEAN JOURNAL OF NUTRITION, 2022, 61 (06) : 2853 - 2871
  • [30] Subject Numbers and Placebo Outcome Variability in Clinical Trials of New CNS Medications
    Derry Ridgway
    Arif Khan
    Gavin Ridgway
    Mark A. Cierpial
    Charles G. Lineberry
    Drug information journal : DIJ / Drug Information Association, 2007, 41 : 701 - 708